Share-based Payment Arrangement, Expense of MESA LABORATORIES INC /CO/ from 31 Mar 2011 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
MESA LABORATORIES INC /CO/ annual and quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2011 to 31 Mar 2025.
  • MESA LABORATORIES INC /CO/ Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $2,928,000, a 1.3% decline year-over-year.
  • MESA LABORATORIES INC /CO/ Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2024 was $11,896,000, a 1.5% decline year-over-year.
  • MESA LABORATORIES INC /CO/ annual Share-based Payment Arrangement, Expense for 2024 was $13,142,000, a 10% increase from 2023.
  • MESA LABORATORIES INC /CO/ annual Share-based Payment Arrangement, Expense for 2023 was $11,936,000, a 4.8% decline from 2022.
  • MESA LABORATORIES INC /CO/ annual Share-based Payment Arrangement, Expense for 2022 was $12,538,000, a 10% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

MESA LABORATORIES INC /CO/ Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $13,142,000 +$1,206,000 +10% 01 Apr 2024 31 Mar 2025 10-K 28 May 2025 2025 FY
2023 $11,936,000 -$602,000 -4.8% 01 Apr 2023 31 Mar 2024 10-K 28 May 2025 2025 FY
2022 $12,538,000 +$1,147,000 +10% 01 Apr 2022 31 Mar 2023 10-K 28 May 2025 2025 FY
2021 $11,391,000 +$2,123,000 +23% 01 Apr 2021 31 Mar 2022 10-K 28 Jun 2024 2024 FY
2020 $9,268,000 +$3,743,000 +68% 01 Apr 2020 31 Mar 2021 10-K 30 May 2023 2023 FY
2019 $5,525,000 +$1,313,000 +31% 01 Apr 2019 31 Mar 2020 10-K 31 May 2022 2022 FY
2018 $4,212,000 +$2,540,000 +152% 01 Apr 2018 31 Mar 2019 10-K 01 Jun 2021 2021 FY
2017 $1,672,000 +$261,000 +18% 01 Apr 2017 31 Mar 2018 10-K 01 Jun 2020 2020 FY
2016 $1,411,000 +$84,000 +6.3% 01 Apr 2016 31 Mar 2017 10-K 03 Jun 2019 2019 FY
2015 $1,327,000 +$334,000 +34% 01 Apr 2015 31 Mar 2016 10-K 05 Jun 2018 2018 FY
2014 $993,000 +$153,000 +18% 01 Apr 2014 31 Mar 2015 10-K 07 Jun 2017 2017 FY
2013 $840,000 -$272,000 -24% 01 Apr 2013 31 Mar 2014 10-K 06 Jun 2016 2016 FY
2012 $1,112,000 +$648,000 +140% 01 Apr 2012 31 Mar 2013 10-K 03 Jun 2015 2015 FY
2011 $464,000 +$81,000 +21% 01 Apr 2011 31 Mar 2012 10-K 04 Jun 2014 2014 FY
2010 $383,000 01 Apr 2010 31 Mar 2011 10-K 06 Jun 2013 2012 FY

MESA LABORATORIES INC /CO/ Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $11,896,000 $2,928,000 -$40,000 -1.3% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2024 2025 Q1
Q1 2024 $11,936,000 $2,792,000 +$113,000 +4.2% 01 Jan 2024 31 Mar 2024 10-K 28 May 2025 2025 FY
Q4 2023 $11,823,000 $2,993,000 +$937,000 +46% 01 Oct 2023 31 Dec 2023 10-Q 05 Feb 2024 2024 Q3
Q3 2023 $10,886,000 $3,183,000 -$1,188,000 -27% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2023 2024 Q2
Q2 2023 $12,074,000 $2,968,000 -$464,000 -14% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2025 Q1
Q1 2023 $12,538,000 $2,679,000 -$773,000 -22% 01 Jan 2023 31 Mar 2023 10-K 28 May 2025 2025 FY
Q4 2022 $13,311,000 $2,056,000 -$1,647,000 -44% 01 Oct 2022 31 Dec 2022 10-Q 05 Feb 2024 2024 Q3
Q3 2022 $14,958,000 $4,371,000 +$2,332,000 +114% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2024 Q2
Q2 2022 $12,626,000 $3,432,000 +$1,235,000 +56% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2024 Q1
Q1 2022 $11,391,000 $3,452,000 +$1,071,000 +45% 01 Jan 2022 31 Mar 2022 10-K 28 Jun 2024 2024 FY
Q4 2021 $10,320,000 $3,703,000 +$92,000 +2.5% 01 Oct 2021 31 Dec 2021 10-Q 06 Feb 2023 2023 Q3
Q3 2021 $10,228,000 $2,039,000 +$31,000 +1.5% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2023 Q2
Q2 2021 $10,197,000 $2,197,000 +$929,000 +73% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2023 Q1
Q1 2021 $9,268,000 $2,381,000 +$2,166,000 +1007% 01 Jan 2021 31 Mar 2021 10-K 30 May 2023 2023 FY
Q4 2020 $7,102,000 $3,611,000 +$351,000 +11% 01 Oct 2020 31 Dec 2020 10-Q 03 Feb 2022 2022 Q3
Q3 2020 $6,751,000 $2,008,000 +$826,000 +70% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2022 Q2
Q2 2020 $5,925,000 $1,268,000 +$400,000 +46% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2022 Q1
Q1 2020 $5,525,000 $215,000 -$1,573,000 -88% 01 Jan 2020 31 Mar 2020 10-K 31 May 2022 2022 FY
Q4 2019 $7,098,000 $3,260,000 +$2,565,000 +369% 01 Oct 2019 31 Dec 2019 10-Q 03 Feb 2021 2020 Q3
Q3 2019 $4,533,000 $1,182,000 +$192,000 +19% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q2
Q2 2019 $4,341,000 $868,000 +$129,000 +17% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q1
Q1 2019 $4,212,000 $1,788,000 +$1,539,000 +618% 01 Jan 2019 31 Mar 2019 10-K 01 Jun 2021 2021 FY
Q4 2018 $2,673,000 $695,000 +$257,000 +59% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020 2020 Q3
Q3 2018 $2,416,000 $990,000 +$545,000 +122% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2020 Q2
Q2 2018 $1,871,000 $739,000 +$199,000 +37% 01 Apr 2018 30 Jun 2018 10-Q 30 Jul 2019 2020 Q1
Q1 2018 $1,672,000 $249,000 +$59,000 +31% 01 Jan 2018 31 Mar 2018 10-K 01 Jun 2020 2020 FY
Q4 2017 $1,613,000 $438,000 +$58,000 +15% 01 Oct 2017 31 Dec 2017 10-Q 04 Feb 2019 2019 Q3
Q3 2017 $1,555,000 $445,000 +$33,000 +8% 01 Jul 2017 30 Sep 2017 10-Q 31 Oct 2018 2019 Q2
Q2 2017 $1,522,000 $540,000 +$111,000 +26% 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018 2019 Q1
Q1 2017 $1,411,000 $190,000 -$136,000 -42% 01 Jan 2017 31 Mar 2017 10-K 03 Jun 2019 2019 FY
Q4 2016 $1,547,000 $380,000 +$36,000 +10% 01 Oct 2016 31 Dec 2016 10-Q 06 Feb 2018 2018 Q3
Q3 2016 $1,511,000 $412,000 +$82,000 +25% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017 2018 Q2
Q2 2016 $1,429,000 $429,000 +$102,000 +31% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017 2018 Q1
Q1 2016 $1,327,000 $326,000 +$109,000 +50% 01 Jan 2016 31 Mar 2016 10-K 05 Jun 2018 2018 FY
Q4 2015 $1,218,000 $344,000 +$84,000 +32% 01 Oct 2015 31 Dec 2015 10-Q 06 Feb 2017 2017 Q3
Q3 2015 $1,134,000 $330,000 +$93,000 +39% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2017 Q2
Q2 2015 $1,041,000 $327,000 +$48,000 +17% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016 2017 Q1
Q1 2015 $993,000 $217,000 +$6,000 +2.8% 01 Jan 2015 31 Mar 2015 10-K 07 Jun 2017 2017 FY
Q4 2014 $987,000 $260,000 -$12,000 -4.4% 01 Oct 2014 31 Dec 2014 10-Q 04 Feb 2016 2016 Q3
Q3 2014 $999,000 $237,000 +$29,000 +14% 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015 2016 Q2
Q2 2014 $970,000 $279,000 +$130,000 +87% 01 Apr 2014 30 Jun 2014 10-Q 04 Aug 2015 2016 Q1
Q1 2014 $840,000 $211,000 -$4,000 -1.9% 01 Jan 2014 31 Mar 2014 10-K 06 Jun 2016 2016 FY
Q4 2013 $844,000 $272,000 -$187,000 -41% 01 Oct 2013 31 Dec 2013 10-Q 02 Feb 2015 2015 Q3
Q3 2013 $1,031,000 $208,000 -$81,000 -28% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2015 Q2
Q2 2013 $1,112,000 $149,000 $0 0% 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014 2015 Q1
Q1 2013 $1,112,000 $215,000 +$100,000 +87% 01 Jan 2013 31 Mar 2013 10-K 03 Jun 2015 2015 FY
Q4 2012 $1,012,000 $459,000 +$302,000 +192% 01 Oct 2012 31 Dec 2012 10-Q 05 Feb 2014 2013 Q3
Q3 2012 $710,000 $289,000 +$193,000 +201% 01 Jul 2012 30 Sep 2012 10-Q 05 Nov 2013 2013 Q2
Q2 2012 $517,000 $149,000 +$53,000 +55% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013 2013 Q1
Q1 2012 $464,000 $115,000 01 Jan 2012 31 Mar 2012 10-K 04 Jun 2014 2014 FY
Q4 2011 $157,000 01 Oct 2011 31 Dec 2011 10-Q 08 Feb 2013 2012 Q3
Q3 2011 $96,000 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012 2012 Q2
Q2 2011 $96,000 01 Apr 2011 30 Jun 2011 10-Q 10 Aug 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.